Limited coverage drugs – ropinirole

Last updated on September 26, 2024
 
Generic name ropinirole
Strength 0.25 mg, 1 mg, 2 mg, 5 mg
Form tablet

Special Authority criteria

Approval period

For the treatment of idiopathic Parkinson's disease, when:

  • the patient is receiving treatment with levodopa and requires additional adjunctive therapy
    OR
  • the patient cannot tolerate or has contraindications to levodopa

 

Indefinite

Practitioner exemptions

  • None

Special notes

  • None

Special Authority requests